Correction: Is there a link between very early changes of primary and secondary lymphoid organs in 18F-FDG-PET/MRI and treatment response to checkpoint inhibitor therapy?

• Yuan Chen,
• Zhibin Xie,
• Kehan Song,
• Zhi-Ying Zhan,
• Yi Yao,
• Hongyun Gong,
• Qun Wang,
• Xiaorong Dong,
• Chun-Quan Ou,
• Qinyong Hu

Affiliations

Yuan Chen

Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Zhibin Xie

chest physician

Kehan Song

Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Zhi-Ying Zhan

State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China

Yi Yao

Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China

Hongyun Gong

Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China

Qun Wang

Department of Oncology, The Fifth Hospital of Wuhan, Wuhan, China

Xiaorong Dong

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Chun-Quan Ou

State Key Laboratory of Organ Failure Research, Department of Biostatistics, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, China

Qinyong Hu

Cancer Center, Renmin Hospital of Wuhan University, Wuhan, China